ArticleClinical case reports2026
A Rare Type of Bullous Disorder in a Child. Can It Be Chronic Bullous Disease of Childhood?
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Rare Type of Bullous Disorder in a Child. Can It Be Chronic Bullous Disease of Childhood?Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic bullous disease of childhood (CBDC), also known as childhood linear IgA bullous dermatosis, is a rare autoimmune disorder characterized by sub-epidermal blistering and linear deposition of immunoglobulin A at the demo-epidermal junction. Clinical manifestations in children include tense bulla (arranged annularly in the form of ring of pearl) and vesicles over the erythematous skin. Diagnosis is confirmed by skin biopsy from lesions showing sub-epidermal blisters in histopathological examination and linear deposition of IgA at the dermal-epidermal junction in direct immunofluorescence. Here, we report a case of CBDC in a 5-year-old child who was treated successfully with oral dapsone showing improvement in the skin lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.